Sutcliffe Siobhan, Bradley Catherine S, Clemens James Quentin, James Aimee S, Konkle Katy S, Kreder Karl J, Lai Hing Hung Henry, Mackey Sean C, Ashe-McNalley Cody P, Rodriguez Larissa V, Barrell Edward, Hou Xiaoling, Robinson Nancy A, Mullins Chris, Berry Sandra H
Division of Public Health Sciences and the Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Avenue, Box 8100, St. Louis, MO, 63110, USA,
Int Urogynecol J. 2015 Jul;26(7):1047-60. doi: 10.1007/s00192-015-2652-6. Epub 2015 Mar 20.
Although in-depth qualitative information is critical to understanding patients' symptom experiences and to developing patient-centered outcome measures, only one previous qualitative study has assessed urological chronic pelvic pain syndrome (UCPPS) symptom exacerbations ("flares").
We conducted eight focus groups of female UCPPS (interstitial cystitis/bladder pain syndrome) patients at four sites from the MAPP Research Network (n = 57, mean = 7/group) to explore the full spectrum of flares and their impact on patients' lives.
Flare experiences were common and varied widely in terms of UCPPS symptoms involved, concurrent nonpelvic symptoms (e.g., diarrhea), symptom intensity (mild to severe), duration (minutes to years), and frequency (daily to < once/year), although the most commonly described flares were painful flares lasting days. These latter flares were also most disruptive to participants' lives, causing some to cancel social events, miss work or school, and in the worst cases, go to the emergency room or on disability leave. Participants also reported a longer-term impact of flares, including negative effects on their sexual functioning and marital, family, and social relationships; and the loss of employment or limited career or educational advancement. Emerging themes included the need for a sense of control over unpredictable symptoms and reduced social engagement.
Given their negative impact, future research should focus on approaches to prevent flares, and to reduce their frequency, severity, and/or duration. Patients' quality of life may also be improved by providing them with a sense of control over their symptoms through ready access to flare medications/therapy, and by engaging them socially.
尽管深入的定性信息对于理解患者的症状体验以及制定以患者为中心的结局指标至关重要,但此前仅有一项定性研究评估了泌尿外科慢性盆腔疼痛综合征(UCPPS)的症状加重情况(“发作”)。
我们在MAPP研究网络的四个地点组织了八组女性UCPPS(间质性膀胱炎/膀胱疼痛综合征)患者(n = 57,每组平均7人),以探讨发作的全貌及其对患者生活的影响。
发作经历很常见,在所涉及的UCPPS症状、并发的非盆腔症状(如腹泻)、症状强度(轻度至重度)、持续时间(数分钟至数年)和发作频率(每天至每年少于一次)方面差异很大,不过最常描述的发作是持续数天的疼痛发作。后一种发作对参与者的生活干扰也最大,导致一些人取消社交活动、旷工或旷课,最糟糕的情况是前往急诊室或休病假。参与者还报告了发作的长期影响,包括对其性功能以及婚姻、家庭和社会关系的负面影响;以及失业或职业或教育发展受限。新出现的主题包括需要对不可预测的症状有掌控感以及减少社交参与。
鉴于发作的负面影响,未来研究应聚焦于预防发作以及降低其频率、严重程度和/或持续时间的方法。通过让患者能够随时获得发作药物/治疗并使其参与社交活动,从而让他们对自身症状有掌控感,这也可能改善患者的生活质量。